Treatment of progressive supranuclear palsy with methysergide. A clinical study

We present a clinical study of a patient aged 69 years with a clinical history of severe difficulty in walking and voluntary conjugate eye movement reduction in sideways glance and absence in vertical gaze. These symptoms led to diagnosis of Parkison disease and treatment with L-Dopa+anticholinergics drugs. The treatment with antiparkinsonian drugs was suspended and no change in his clinical condition resulted.